Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of the HEP (Homeostasis-Enrichment-Plasticity) Approach in Infants With Down Syndrome

NCT07163780 is registered in ClinicalTrials.gov with Izgi Miray Demirbag as lead sponsor.

NCT NCT07163780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07163780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of the HEP (Homeostasis-Enrichment-Plasticity) Approach in Infants With Down Syndrome
Lead sponsor
Izgi Miray Demirbag
Phase
Not applicable
Overall status
Recruiting
Start date
September 3, 2025
Completion date
December 3, 2025
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome (ds)